Literature DB >> 11991645

Regulation of alternative splicing by SRrp86 through coactivation and repression of specific SR proteins.

Daron C Barnard1, Jun Li, Rui Peng, James G Patton.   

Abstract

SRrp86 is an 86-kDa member of the SR protein superfamily that is unique in that it can alter splice site selection by regulating the activity of other SR proteins. To study the function of SRrp86, inducible cell lines were created in which the concentration of SRrp86 could be varied and its effects on alternative splicing determined. Here, we show that SRrp86 can activate SRp20 and repress SC35 in a dose-dependent manner both in vitro and in vivo. These effects are apparently mediated through direct protein-protein interaction, as pull-down assays showed that SRrp86 interacts with both SRp20 and SC35. Consistent with the hypothesis that relatively modest changes in the concentration or activity of one or more splicing factors can combinatorially regulate overall splicing, protein expression patterns of SRrp86, SRp20, and SC35 reveal that each tissue maintains a unique ratio of these factors. Regulation of SR protein activity, coupled with regulated protein expression, suggest that SRrp86 may play a crucial role in determining tissue specific patterns of alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991645      PMCID: PMC1370273          DOI: 10.1017/s1355838202029928

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  39 in total

Review 1.  Determinants of SR protein specificity.

Authors:  R Tacke; J L Manley
Journal:  Curr Opin Cell Biol       Date:  1999-06       Impact factor: 8.382

2.  ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome.

Authors:  L Croft; S Schandorff; F Clark; K Burrage; P Arctander; J S Mattick
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

Review 3.  SR proteins and splicing control.

Authors:  J L Manley; R Tacke
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

Review 4.  Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.

Authors:  A J Lopez
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

5.  Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins.

Authors:  A Kanopka; O Mühlemann; S Petersen-Mahrt; C Estmer; C Ohrmalm; G Akusjärvi
Journal:  Nature       Date:  1998-05-14       Impact factor: 49.962

6.  Antagonism between RSF1 and SR proteins for both splice-site recognition in vitro and Drosophila development.

Authors:  E Labourier; H M Bourbon; I E Gallouzi; M Fostier; E Allemand; J Tazi
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

7.  Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability.

Authors:  J Wang; Y Takagaki; J L Manley
Journal:  Genes Dev       Date:  1996-10-15       Impact factor: 11.361

Review 8.  The superfamily of arginine/serine-rich splicing factors.

Authors:  X D Fu
Journal:  RNA       Date:  1995-09       Impact factor: 4.942

9.  The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Authors:  S K Petersen-Mahrt; C Estmer; C Ohrmalm; D A Matthews; W C Russell; G Akusjärvi
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

10.  Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.

Authors:  A Hanamura; J F Cáceres; A Mayeda; B R Franza; A R Krainer
Journal:  RNA       Date:  1998-04       Impact factor: 4.942

View more
  9 in total

1.  Analysis of SRrp86-regulated alternative splicing: control of c-Jun and IκBβ activity.

Authors:  Amanda S Solis; James G Patton
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

2.  Familial 5q12.3 Microdeletion: Evidence for a Locus Associated with Epilepsy.

Authors:  Chiara Gnan; Alessandra Franzoni; Federica Baldan; Nadia Passon; Giuseppe Damante; Patrizia Dello Russo
Journal:  Mol Syndromol       Date:  2017-01-17

3.  NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.

Authors:  Rachel A Katzenellenbogen; Erin M Egelkrout; Portia Vliet-Gregg; Lindy C Gewin; Philip R Gafken; Denise A Galloway
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

4.  Regulation of alternative splicing by SRrp86 and its interacting proteins.

Authors:  Jun Li; Ian C Hawkins; Christopher D Harvey; Jennifer L Jennings; Andrew J Link; James G Patton
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

5.  Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II.

Authors:  Robin C C Ryther; Lindsay M McGuinness; John A Phillips; Chanda T Moseley; Charalambos B Magoulas; Iain C A F Robinson; James G Patton
Journal:  Hum Genet       Date:  2003-04-29       Impact factor: 4.132

6.  The splicing regulatory protein p18SRP is down-regulated in Alzheimer's disease brain.

Authors:  Klaus Heese; Masako Fujita; Hiroyasu Akatsu; Takayuki Yamamoto; Kenji Kosaka; Yasuo Nagai; Tohru Sawada
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  A novel SR-related protein is required for the second step of Pre-mRNA splicing.

Authors:  Demian Cazalla; Kathryn Newton; Javier F Cáceres
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 8.  The RNA Splicing Response to DNA Damage.

Authors:  Lulzim Shkreta; Benoit Chabot
Journal:  Biomolecules       Date:  2015-10-29

9.  The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Authors:  Cunjie Chang; Muthukumar Rajasekaran; Yiting Qiao; Heng Dong; Yu Wang; Hongping Xia; Amudha Deivasigamani; Minjie Wu; Karthik Sekar; Hengjun Gao; Mengqing Sun; Yuqin Niu; Qian Li; Lin Tao; Zhen Yan; Menglan Wang; Shasha Chen; Shujuan Zhao; Dajing Chen; Lina Li; Fan Yang; Haojin Gao; Baodong Chen; Ling Su; Liang Xu; Ye Chen; Veerabrahma Pratap Seshachalam; Gongxing Chen; Jayantha Gunaratne; Wanjin Hong; Junping Shi; Gongying Chen; David S Grierson; Benoit Chabot; Tian Xie; Kam Man Hui; Jianxiang Chen
Journal:  Nat Commun       Date:  2022-03-16       Impact factor: 17.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.